Delivery Order SPE2DB24D1205-SPE2DB25FDAAJ
Award Date 9/2/25
Potential Completion Date 9/3/25
Potential Value $12K
Federal Agency
Awardee
Ultimate Awardee
Not listed PSC Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $1,413.35 to AmerisourceBergen Drug Corp for the supply of Ondansetron HCL 4 mg tablets (30-count) on July 18, 2025, with an ultimate completion date of July 21, 2025. This is a firm fixed-price, competitively awarded contract with no set-aside designation. AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, performs this work at its corporate office location. The...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $7,950.66 to AmerisourceBergen Drug Corp for the supply of Ondansetron HCL 8 mg tablets in quantities of 30 units. This firm fixed price delivery order, issued on September 15, 2025, with an ultimate completion date of September 16, 2025, represents a competitively awarded non-set-aside contract executed under an existing indefinite delivery vehicle. The product will be delivered to AmerisourceBergen's corporate office...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $2,428.52 to AmerisourceBergen Drug Corp for Ondansetron HCl 4 mg tablets (30-count) on April 24, 2025, with completion scheduled for April 25, 2025. This competitive award uses firm fixed pricing and does not include a set-aside designation. The pharmaceutical product will be delivered to the company's corporate office location in Conshohocken, Pennsylvania, which serves as AmerisourceBergen's headquarters and primary...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 12, 2025, for the supply of Ondansetron HCL 4 mg tablets (500 tablets) with a ceiling value of $5,367.10. This is a firm fixed-price delivery order with an ultimate completion date of August 13, 2025, and represents a non-set-aside competitive award. The product will be supplied from AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is a child contract...
- The Defense Logistics Agency awarded a delivery order valued at $14,466.96 to AmerisourceBergen Drug Corp on July 18, 2025, for the supply of Ondansetron HCL 4 mg tablets in quantities of 30. The contract represents a firm fixed-price delivery order with no set-aside designation, indicating competitive award. Performance will be executed from AmerisourceBergen's facility in Conshohocken, Pennsylvania, with an ultimate completion date of July 21, 2025. This delivery order is issued under...
- The Defense Logistics Agency awarded a delivery order valued at $3,651.47 to AmerisourceBergen Drug Corp for the supply of Ondansetron HCL 4 mg tablets (30 count) on September 9, 2025, with an ultimate completion date of September 10, 2025. This is a firm fixed-price, non-set-aside contract with performance taking place at AmerisourceBergen's corporate office in Conshohocken, Pennsylvania. The award represents a continuation of the company's critical role as a pharmaceutical distributor...
- The Defense Logistics Agency (DLA) awarded a delivery order to AmerisourceBergen Drug Corp on September 2, 2025, for the supply of Ondansetron HCL 4 mg tablets (500-count packages) valued at $13,519.08. This competitively awarded, firm fixed-price contract is non-set-aside and represents a child order under AmerisourceBergen's broader pharmaceutical supply relationship with DLA. The place of performance is located at the vendor's corporate office in Conshohocken, Pennsylvania, with an ultimate...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 29, 2025, for the supply of Ondansetron HCl 4 mg tablets in quantities of 30, with a ceiling value of $23,438.54. This is a firm fixed price delivery order with no set-aside designation, completed through open competition. The order is scheduled for ultimate completion by September 2, 2025, and will be performed at AmerisourceBergen's facility in Conshohocken, Pennsylvania. This delivery order falls...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $3,724.62 to AmerisourceBergen Drug Corp for Ondansetron HCL 4 mg tablets (30-count) on July 15, 2025, with an ultimate completion date of July 16, 2025. This firm fixed-price delivery order represents a non-set-aside competitive award and will be performed at the awardee's corporate office location in Conshohocken, Pennsylvania. AmerisourceBergen Drug Corp is a major pharmaceutical distributor serving as a critical vendor for...
- The Defense Logistics Agency awarded a delivery order valued at $2,566.01 to AmerisourceBergen Drug Corp for the supply of Ondansetron HCL 4 mg tablets (30-count packaging) under a firm fixed price contract. The award was issued on September 19, 2025, with an ultimate completion date of September 22, 2025, and represents a non-set-aside competitive award. Performance will occur at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under...